New approach methods (NAMs) supporting read-across: Two neurotoxicity AOP-based IATA case studies


Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2021
Historique:
received: 05 03 2021
accepted: 01 06 2021
entrez: 11 6 2021
pubmed: 12 6 2021
medline: 28 10 2021
Statut: ppublish

Résumé

Read-across approaches are considered key in moving away from in vivo animal testing towards addressing data-gaps using new approach methods (NAMs). Ample successful examples are still required to substantiate this strategy. Here we present and discuss the learnings from two OECD IATA endorsed read-across case studies. They involve two classes of pesticides – rotenoids and strobilurins – each having a defined mode-of-action that is assessed for its neurological hazard by means of an AOP-based testing strategy coupled to toxicokinetic simulations of human tissue concentrations. The endpoint in question is potential mitochondrial respiratory chain mediated neurotoxicity, specifically through inhibition of complex I or III. An AOP linking inhibition of mitochondrial respiratory chain complex I to the degeneration of dopaminergic neurons formed the basis for both cases but was deployed in two different regulatory contexts. The two cases also exemplify several different read-across concepts: analogue versus category approach, consolidated versus putative AOP, positive versus negative prediction (i.e., neurotoxicity versus low potential for neurotoxicity), and structural versus biological similarity. We applied a range of NAMs to explore the toxicodynamic properties of the compounds, e.g., in silico docking as well as in vitro assays and readouts – including transcriptomics – in various cell systems, all anchored to the relevant AOPs. Interestingly, although some of the data addressing certain elements of the read-across were associated with high uncertainty, their impact on the overall read-across conclusion remained limited. Coupled to the elaborate regulatory review that the two cases underwent, we propose some generic learnings of AOP-based testing strategies supporting read-across.

Identifiants

pubmed: 34114044
doi: 10.14573/altex.2103051
doi:

Substances chimiques

Pesticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

615-635

Auteurs

Wanda Van der Stel (W)

Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.

Giada Carta (G)

Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, AIMMS, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Julie Eakins (J)

Cyprotex Discovery Ltd., Alderley Park, Macclesfield, Cheshire, United Kingdom.

Johannes Delp (J)

Chair for In vitro Toxicology and Biomedicine, Department of Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.

Ilinca Suciu (I)

Chair for In vitro Toxicology and Biomedicine, Department of Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.
Konstanz Research School Chemical Biology, University of Konstanz, Konstanz, Germany.

Anna Forsby (A)

Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

Andrea Cediel-Ulloa (A)

Department of Organismal Biology, Uppsala University, Uppsala, Sweden.

Kristina Attoff (K)

Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.

Florentina Troger (F)

Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.

Hennicke Kamp (H)

BASF, Ludwigshafen, Germany.

Iain Gardner (I)

Certara UK Limited, Sheffield, United Kingdom.

Barbara Zdrazil (B)

Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.

Martijn J Moné (MJ)

Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.

Gerhard F Ecker (GF)

Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.

Manuel Pastor (M)

Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Spain.

Jose Carlos Gómez-Tamayo (JC)

Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Spain.

Andrew White (A)

Unilever, Bedfordshire, United Kingdom.

Erik H J Danen (EHJ)

Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.

Marcel Leist (M)

Chair for In vitro Toxicology and Biomedicine, Department of Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.

Paul Walker (P)

Cyprotex Discovery Ltd., Alderley Park, Macclesfield, Cheshire, United Kingdom.

Paul Jennings (P)

Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, AIMMS, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Susanne Hougaard Bennekou (S)

National Food Institute Technical University of Denmark (DTU), Lyngby, Denmark.

Bob Van de Water (B)

Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH